
384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen
The Readout Loud
00:00
Outlook for U.S. biotech and pharma ties
Bob shares optimism mixed with caution about capital flows, M&A, and biotech's future.
Play episode from 57:26
Transcript


